Exchange: NASDAQ·Updated 07:30 PM EST
STAA logo

STAA Staar Surgical Co.

$24.22
$0.81
(3.24%)
Today
Closed $24.22
$0.00
(0.00%)
After Hours
Reported EarningsNov 4
Mkt Cap$1.22B
Vol585,638.00

About STAA

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
38

Bearish Sentiment

How do you feel about STAA?

Bogwood
$STAA I think most "next quarter" traders don't understand this earnings call implications for evo+ sell-in rates. More color was given on the Stifel conference yesterday, and this is part of the schizo giga thesis that could easily re-rate us to $50 by 1Q27 and beyond. If you're new, this is the core of what Alcon saw in a potential acquisition: China's asp could easily be doubled with no impact to consumer price paid, and thus demand. This is only possible because of how much mark-up Lansheng and other distributors have taxed STAAR with since coming to market. Attached image shows comparable medtech products. It's a fun question to think through- who has more leverage now that EVO is a recognized name through word of mouth? Can STAAR make up more of this 12K Yuan pie? Unit volumes don't have to increase at all to reflect a doubling of sales... Truly extraodinary to project the implications when combined when volumes do grow and more Chinese surgeons are trained...
5
Bogwood
$STAA Sentiment starting to turn around... The future of refractive surgery- it's a rEVOlution!
5
scalperD
$STAA - the stock that never fails to disappoint. Now would be a good time to implement that buyback.
1
StocktwitsEarnings
$STAA Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.11 down -83.82% YoY • Reported revenue of $83.41M up 21.24% YoY • STAAR Surgical does not expect to achieve its 75% target gross margin in 2026, and expects gross margin to improve in the fourth quarter of 2026.
1

Advertisement|Remove ads.